Parapsoriasishttps://en.wikipedia.org/wiki/Parapsoriasis
Parapsoriasis dia manondro ny iray amin'ireo vondron'ny aretin'ny hoditra izay miavaka indrindra amin'ny fitovizan'izy ireo amin'ny psoriasis (ratra mena sy mikolo). Parapsoriasis dia dermatoses lymphoproliferative hoditra tsy fahita firy izay mitranga indrindra amin'ny olon-dehibe efa antitra, ny 2/3 amin'izy ireo dia lahy.

Ny homamiadan'ny hoditra dia mety hivoatra avy amin'ny parapsoriasis. Ohatra, mety hivoatra ho lymphoma sela T hoditra izy io.

Diagnose sy fitsaboana
Fitsapana ra hanalana ny sifilis
Biopsy mba hanesorana ny lymphoma hoditra

☆ Tamin'ny valin'ny Stiftung Warentest 2022 avy any Alemaina, ny fahafaham-pon'ny mpanjifa amin'ny ModelDerm dia ambany kely noho ny fifampidinihana telemedicine karama.
      References Parapsoriasis-A Diagnosis with an Identity Crisis: A Narrative Review 35426607 
      NIH
      Parapsoriasis is an uncommon inflammatory skin disease characterized by chronic patches that may be resistant to therapy. It was primarily introduced and classified 120 years ago, and the original classification incorporated parapsoriasis and pityriasis lichenoides under the umbrella term parapsoriasis. After a major change in classification, parapsoriasis now exclusively refers to small plaque parapsoriasis (SPP) and large plaque parapsoriasis (LPP). However, debates still frequently occur regarding various nomenclatures and classifications used by different authors. Moreover, parapsoriasis may progress to overt cutaneous lymphoma, most commonly mycosis fungoides (MF), and it is very difficult to distinguish these two conditions despite modern histologic and molecular testing techniques.
       Histopathologic Evaluation of Parapsoriasis from the Perspective of NB-UVB/PUVA Therapy on the Outcome and Recurrence of the Disease 33911303 
      NIH
      Parapsoriasis, presented as an early stage of cutaneous T-cell lymphoma, is mostly treated with psoralen and ultraviolet A (PUVA) therapy and narrowband ultraviolet B (NB-UVB) phototherapy.